Benefits of accelerated hyperfractionation for head and neck cancer

Acta Oncologica

Volumn 38, Issue 2, 1999, Pages 131-135

  Cummings, Bernard J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COST BENEFIT ANALYSIS; HEAD CANCER; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; REVIEW; TISSUE REPAIR; TREATMENT OUTCOME;

EID: 0032903164     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431528     Document Type: Review

References (24)

1. 1. Withers HR, McBride WH. Biologic basis of radiation therapy. In: Perez CA, Brady LW, ed. Principles and practice of radiation oncology. Third edition. Philadelphia: Lipincott Raven, 1997: 79-118.
2. 2. Ang KK, Thames HD, Peters LJ. Altered fractionation schedules. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, Third edition. Philadelphia: Lipincott-Raven, 1997: 119-42.
3. 3. Harwood AR, Keane TJ. General principles of irradiation therapy as applied to head and neck cancer. J Otolaryngol 1982; 11: 69-76.
4. 4. Dose specification for reporting external beam therapy with photons and electrons. Report 29: International Commission on Radiation Units and Measurements (ICRU). Washington, USA, 1978.
5. 5. Withers HR, Peters LJ, Taylor JM, et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995; 33: 549-62.
6. 6. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 4th ed., Genève: UICC, 1987.
7. 7. Fowler JF. JF Kirk Memorial Lecture: What next in fractionated radiotherapy? Br J Cancer 1984; 49 (Suppl 6): 285S-300S.
8. 8. Withers HR. Biologic basis for altered fractionation schemes. Cancer 1985; 55: 2086-95.
9. 9. Horiot JC, Chaplain G, van der Schueren E, Gonzalez Gonzalez D, van den Bogaert W, van Limbergen E. A phase III study of accelerated fractionation in the radiotherapy of advanced head and neck carcinoma. EORTC Cooperative Group of Radiotherapy Protocol 22851, EORTC Data Center Brussels, 1985.
10. 10. Million RR, Parsons JT, Cassisi NJ. Twice-a-day irradiation technique for squamous cell carcinomas of the head and neck. Cancer 1985; 55: 2096-9.
11. 11. Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100-4.
12. 12. Cummings BJ, Keane TJ, Pintille M, et al. A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx (abstract). Radiother Oncol 1996; 40 (Suppl 1): 30S.
13. 13. Davidson J, Keane T, Brown D, et al. Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123: 420-4.
14. 14. Dische S, Saunders M, Barrett A, Harve A, Gibson D, Parmar M. A randomized multicenter trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44: 123-36.
15. 15. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111-21.
16. 16. Van den Bogaert W, van der Schueren E, Horiot JC, et al. The feasibility of high dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1982; 8: 1649-55.
17. 17. Ang KK. Accelerated fractionation: what is the price for speeding? Radiother Oncol 1997; 44: 97-9.
18. 18. Coyle D, Drummond M. Costs of conventional radical radiotherapy versus continuons hyperfractionated accelerated radical radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus Medical Research Council CHART Steering Committee. Clin Oncol 1997; 9: 313-21.
19. 19. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997; 37: 259-67.
20. 20. Sanchiz F, Milla A, Torner J, Bonet F, Artola N, Carreno L. Single fraction per day vs. two fractions per day vs. radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1347-50.
21. 21. Horiot JC, Le Fur R, Nguyen TD, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231-41.
22. 22. Datta NR, Choudhry AD, Gupta S, Bose AK. Twice a day versus once a day radiation therapy in head and neck cancer (abstract). Int J Radiat Oncol Biol Phys 1989; 17 (Suppl 1): 132S-133.
23. 23. Pinto LHJ, Canary PCV, Araújo CMM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated vs. conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 557-62.
24. 24. Beck-Bornholdt HP, Dubben HH, Liertz-Petersen C, Willers H. Hyperfractionation: where do we stand? Radiother Oncol 1997; 43: 1-21.